Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery
Background: The efficacy of the treatment of type 1 diabetes can be markedly improved using artificial pancreas (AP), which is a technology to automatically control blood glucose levels. Aim: In this paper, we propose the construction of a controller for controlling the automated delivery of insu...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2018-03-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://dia-endojournals.ru/dia/article/viewFile/8265/7111 |
id |
doaj-bc4e861935e44709905fd92bbd72ef64 |
---|---|
record_format |
Article |
spelling |
doaj-bc4e861935e44709905fd92bbd72ef642021-06-02T19:24:42ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782018-03-01211586510.14341/DM82658413Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin deliveryVladimir A. Karpelyev0Yury I. Philippov1Artem V. Averin2Maxim D. Boyarsky3Dmitriy A. Gavrilov4Endocrinology Research CentreEndocrinology Research CentreMoscow Institute of Physics and TechnologyEndocrinology Research CentreMoscow Institute of Physics and TechnologyBackground: The efficacy of the treatment of type 1 diabetes can be markedly improved using artificial pancreas (AP), which is a technology to automatically control blood glucose levels. Aim: In this paper, we propose the construction of a controller for controlling the automated delivery of insulin in AP based on a proportionalintegralderivative (PID) algorithm using intraperitoneal (IP) insulin delivery. Methods: The project used rapid-acting insulin in the IP space when setting up a PID controller with feedback to ensure the safe and efficient delivery of insulin. The controller was configured to satisfy feedback insulin present in blood. Controller check was performed In Silico using the metabolic simulator UVA|Padova T1DMS on 10 virtual patients. Results: The proposed controller design has time to reach 83% within the glycaemic range of 70140 mg/dl (3.97.8 mmol/l), without time spent in hypoglycaemia. Conclusions: In a future study we plan to test this controller in vivo to evaluate its performance in vivo.https://dia-endojournals.ru/dia/article/viewFile/8265/7111аrtificial pancreasintraperitoneal insulin infusionin silicocontrol algorithminsulin pumppreclinical studies |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vladimir A. Karpelyev Yury I. Philippov Artem V. Averin Maxim D. Boyarsky Dmitriy A. Gavrilov |
spellingShingle |
Vladimir A. Karpelyev Yury I. Philippov Artem V. Averin Maxim D. Boyarsky Dmitriy A. Gavrilov Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery Сахарный диабет аrtificial pancreas intraperitoneal insulin infusion in silico control algorithm insulin pump preclinical studies |
author_facet |
Vladimir A. Karpelyev Yury I. Philippov Artem V. Averin Maxim D. Boyarsky Dmitriy A. Gavrilov |
author_sort |
Vladimir A. Karpelyev |
title |
Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery |
title_short |
Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery |
title_full |
Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery |
title_fullStr |
Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery |
title_full_unstemmed |
Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery |
title_sort |
development and in silico validation of the pid-algorithm for the artificial pancreas with intraperitoneal insulin delivery |
publisher |
Endocrinology Research Centre |
series |
Сахарный диабет |
issn |
2072-0351 2072-0378 |
publishDate |
2018-03-01 |
description |
Background: The efficacy of the treatment of type 1 diabetes can be markedly improved using artificial pancreas (AP), which is a technology to automatically control blood glucose levels.
Aim: In this paper, we propose the construction of a controller for controlling the automated delivery of insulin in AP based on a proportionalintegralderivative (PID) algorithm using intraperitoneal (IP) insulin delivery.
Methods: The project used rapid-acting insulin in the IP space when setting up a PID controller with feedback to ensure the safe and efficient delivery of insulin. The controller was configured to satisfy feedback insulin present in blood. Controller check was performed In Silico using the metabolic simulator UVA|Padova T1DMS on 10 virtual patients.
Results: The proposed controller design has time to reach 83% within the glycaemic range of 70140 mg/dl (3.97.8 mmol/l), without time spent in hypoglycaemia.
Conclusions: In a future study we plan to test this controller in vivo to evaluate its performance in vivo. |
topic |
аrtificial pancreas intraperitoneal insulin infusion in silico control algorithm insulin pump preclinical studies |
url |
https://dia-endojournals.ru/dia/article/viewFile/8265/7111 |
work_keys_str_mv |
AT vladimirakarpelyev developmentandinsilicovalidationofthepidalgorithmfortheartificialpancreaswithintraperitonealinsulindelivery AT yuryiphilippov developmentandinsilicovalidationofthepidalgorithmfortheartificialpancreaswithintraperitonealinsulindelivery AT artemvaverin developmentandinsilicovalidationofthepidalgorithmfortheartificialpancreaswithintraperitonealinsulindelivery AT maximdboyarsky developmentandinsilicovalidationofthepidalgorithmfortheartificialpancreaswithintraperitonealinsulindelivery AT dmitriyagavrilov developmentandinsilicovalidationofthepidalgorithmfortheartificialpancreaswithintraperitonealinsulindelivery |
_version_ |
1721401757948444672 |